Bigdna Ltd

Overview

Legal name

BIGDNA LTD

Region

Scotland

Registered address

1 MILLAR GROVE

HAMILTON

SCOTLAND

ML3 9BF

Insolvency history

No

Corporate ownership

Updated 06 Jun 2026 16:52

Controls 1

Bigdna Ltd

No active corporate controller recorded.

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

0

Company events

Reference milestones and recent Companies House filing stream events.

6 events

31 Dec

2026

Accounts due

Accounts Due

Next accounts due date

17 Nov

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

03 Nov

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar

2025

Accounts filed

Accounts

Last accounts made up date

14 Nov

2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MzQ2MTEzNWFkaXF6a2N4

Published 14 Nov 2024 08:08

03 Nov

2006

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2013

Funded years

2013, 2014

Age at first award

6 years

Projects

2014 GRD Proof of Market Lead participant

IP and commercial assessment of a novel cancer therapeutic

1 May 2014 to 31 Aug 2014

Awarded

£25,000

Total cost £43,532

BigDNA is a vaccine development company, using bacteriophages to deliver DNA vaccines. Arising as an additional output from a previous TSB SMART Proof of Concept project, the Company has identified a novel non-vaccine peptide-based cancer therapy which it believes may have significant clinical and commercial potential. This novel peptide combination has t...

2013 GRD Proof of Concept Lead participant

Optimisation of bacteriophage M13-based DNA and chimeric (DNA/ protein) vaccines

1 Feb 2013 to 31 Jan 2014

Awarded

£95,000

Total cost £161,190

Bacteriophage (phage) offer the potential to deliver both protein and DNA vaccines within the same construct. They also promise extremely rapid development and manufacturing timescales, since the DNA vaccine cassette can be synthesised to express antigens for virtually any pathogen, literally within days following sequence identification. Phage are extrem...

Product types

GRD Proof of Concept GRD Proof of Market